Introduction
Cyclin-dependent kinases (cdks) govern discrete transitions throughout the cell division cycle (Norbury and Nurse, 1992; Reed, 1992) . In mammalian cells, dierent cyclins (regulatory subunits) assemble combinatorially into complexes with several cdks (catalytic subunits) to form holoenzymes that phosphorylate key physiologic substrates during dierent phases of the cell cycle (Pines, 1993; Sherr, 1993) . When cells are stimulated by mitogens to enter the division cycle, the ®rst holoenzymes to be activated are the cyclin Ddependent kinases, cdk4 and cdk6 (Matsushime et al., 1994; Meyerson and Harlow, 1994) . Cyclin D-cdk complexes act as growth factor sensors, initiating the phosphorylation of the retinoblastoma protein (Rb), thereby helping to reverse Rb-mediated repression of a series of genes whose functions are required for DNA synthesis and entry into the DNA synthetic (S) phase of the cycle Kato et al., 1993; Sherr, 1993 Sherr, , 1994 Weinberg, 1995) . Inactivation of Rb is completed by cyclin E-cdk2 complexes (Hinds et al., 1992; Hatakeyama et al., 1994; Connell-Crowley et al., 1997; Lundberg and Weinberg, 1998) , which, together with cyclin A-cdk2, is likely to initiate DNA replication per se (Stillman, 1996; Krude et al., 1997) . Once cells have entered S phase, subsequent transitions through G2 phase are mediated by cyclin A-dependent cdk2 and cdc2 (cdk1), and, during mitosis, by the cyclin B-cdc2 complex, a universal regulator of mitotic entry and exit in all eukaryotic cells (King et al., 1994; Nurse, 1994) .
Apart from their assembly with cyclins, cdk activity is subject to other levels of control (Morgan, 1995; Lew and Kornbluth, 1996) . First, assembled cyclin-cdk holoenzymes remain inactive until the bound cdk subunit is phosphorylated on its activation loop at a single threonine residue (Thr-161 in cdc2, Thr-160 in cdk2, and Thr-172 in cdk4). This phosphorylation is mediated by the cdk-activating kinase (CAK), which in mammalian cells is itself a cyclin-dependent kinase composed of cyclin H and cdk7 Makela et al., 1994; Matsuoka et al., 1994) . Cdk activity is opposed by polypeptide inhibitors of the Cip/ Kip family (p21 Cip1 , p27 Kip1 , p57 Kip2 ) which can interfere with CAK-mediated activation of the assembled holoenzymes as well as extinguish the activity of the CAK-phosphorylated complexes (Elledge and Harper, 1994; Sherr and Roberts, 1995) . Whereas the Cip/Kip proteins act globally, a second family of inhibitors (the INK4 proteins) acts only on the cyclin D-dependent kinases (Peters, 1994; Sherr and Roberts, 1995) . Quiescent cells accumulate high levels of p27 Kip1 , but once cells enter cycle, the progressive formation of cyclin D-dependent kinases sequesters much of the available p27 Kip1 , lowering its eective inhibitory threshold Sherr and Roberts, 1995; Reynisdottir and MassagueÂ , 1997; Cheng et al., 1998) . This allows subsequent activation of cyclin E-cdk2, which phosphorylates p27
Kip1 and triggers its abrupt degradation late in G1 phase Shea et al., 1997) . Molecular events occurring near or at the G1/S transition therefore include (i) Rb phosphorylation, (ii) activation of cyclin E-cdk2, (iii) p27
Kip1 degradation, (iv) induction of cyclin A and appearance of cyclin A-cdk2 activity, and (v), by de®nition, the initiation of DNA synthesis.
Cdks are also negatively regulated by phosphorylation within their ATP-binding site at threonine-14 and tyrosine-15 (Krek and Nigg, 1991; Gu et al., 1992; Morgan, 1995) . These inhibitory phosphorylations result from the action of the wee1/mik1 family of kinases (Lundgren et al., 1991; Atherton-Fessler et al., 1993; McGowan and Russell, 1995) and are reversed by cdc25 phosphatases (Gautier et al., 1991; Draetta and Eckstein, 1997) . Three cdc25 phosphatases have been identi®ed in mammals, and the dierent isoforms, designated A, B, and C, share 40 ± 50% amino acid identity (Sandhu et al., 1990; Nagata et al., 1991; Galaktionov and Beach, 1991) . Only the role of cdc25C has been clearly de®ned. This enzyme preferentially acts to remove inhibitory phosphates from the cyclin B-cdc2 holoenzyme, triggering its activation at the G2/M transition and initiating the onset of mitosis (Atherton-Fessler et al., 1993; Homann et al., 1993) . Furthermore, recent evidence pinpointed a crucial role for cdc25C as a G2 checkpoint-arrest target (Furnari et al., 1997; Peng et al., 1997; Sanchez et al., 1997) .
While cdc25A and cdc25B can dephosphorylate cyclin-cdk2 complexes in vitro (Homann et al., 1994; Tiefenbrun et al., 1996; Xu and Burke, 1996; Saha et al., 1997) , their in vivo substrates have not been formally assigned. The cdc25A gene is induced in G1 phase (Jinno et al., 1994) in agreement with the idea that the enzyme may act on cdk2-containing complexes, which must be activated during this interval for cells to enter S phase. Microinjection of cdc25A-speci®c antibodies into ®broblasts arrests them in G1 phase, implying that this phosphatase is required for S phase entry (Jinno et al., 1994) . Conversely, cdc25A is induced by the c-myc protein (Galaktionov et al., 1996) , a mitogen-responsive transcription factor whose functions are also rate-limiting during G1 progression (Karn et al., 1989; Eilers et al., 1991; Roussel et al., 1991) . Cdc25B is expressed later in the cell cycle in S phase and G2-phase (Jinno et al., 1994) . Both, cdc25A and cdc25B are capable of transforming primary mouse ®broblasts when coexpressed with activated forms of ras, implying that these genes can promote cell proliferation, at least when overexpressed (Galaktionov et al., 1995b) .
We have analysed the role of cdc25A during the cell cycle by establishing ®broblast cell lines that overexpress the protein. Although our data are consistent with the idea that cdc25A acts as a positive growth regulator that is able to contract the G1 interval, we have been unable to martial evidence that the physiologic in vivo substrate of the cdc25A phosphatase is cdk2.
Results

Establishment of cell lines overexpressing human cdc25A
NIH3T3 cells bearing a mitogenically defective colonystimulating factor-1 receptor [CSF-1R (Y809F)] do not form colonies in semi-solid medium when plated in the presence of serum and CSF-1. However, CSF-1-dependent mitogenicity is rescued when ectopic c-myc expression is enforced in the cells . Because, expression of the cdc25A gene is regulated by c-myc (Galaktionov et al., 1996) , we were interested in exploring a possible functional relationship between cdc25A and c-myc in these cells. Cells expressing CSF-1R (Y809F) were co-transfected with a mammalian expression vector encoding human cdc25A together with a second vector plasmid specifying puromycin resistance. Transfected cultures were propagated for 3 weeks in complete serum-containing medium containing puromycin, and surviving transformants were then plated in semisolid medium containing human recombinant CSF-1. Although cells transfected with the puromycin-resistance plasmid alone were unable to form any colonies in agar in response to serum plus CSF-1, enforced expression of cdc25A rescued CSF-1-dependent mitogenicity ( Table 1 ), implying that cdc25A, like Myc, provides a growth-promoting function that complements the defect in receptor signaling. No colonies were detected without CSF-1 stimulation, but about 12% of plated cells formed CSF-1 responsive colonies in agar, a frequency which approximates that obtained with c-myc transformants. Inhibition of c-myc function in such cells using a dominant-negative myc mutant (In373), or the myc antagonist mad, prevented cells overexpressing cdc25A from entering S phase (Table 1) . Moreover, while mycrescued cells can be propagated in chemically de®ned medium containing CSF-1 as the only exogenous growth factor (Roussel and Sherr, 1989; , the cdc25A-rescued clones also required serum to grow (negative data not shown). Therefore, cdc25A does not replace the S phase promoting function of c-myc during rescue, but instead facilitates their anchorage-independent growth in the presence of both serum and CSF-1.
Several CSF-1 responsive agar colonies were picked at random, expanded, and characterized in detail for cdc25A function. Levels of cdc25A protein expression were evaluated in the uncloned, puromycin-resistant mass population of cdc25A transfectants and in CSF-1 responsive single-cell clones by immunoblotting with an antibody that recognizes both the human and mouse cdc25A proteins (Figure 1 ). In parental untransfected cells, endogenous mouse cdc25A protein was not readily detected in quiescent, contact-inhibited ®broblasts (lane 1) but was expressed at much higher levels in proliferating cells (lane 2). Cells transfected with a vector plasmid expressing cdc25A, expressed signi®cantly higher levels of cdc25A protein than their untransfected counterparts, whether arrested (lane 3) 2) . The fact that ectopically expressed human cdc25A accumulates to higher levels in proliferating (lanes 6 to 8) versus contact-inhibited (lanes 3 to 5) cells, implies that accumulation of the protein is post-transcriptionally regulated. Moreover, while human cdc25A provided a function that complemented CSF-1R (Y809F) signaling, very high levels of cdc25A expression may be detrimental to cell growth, as all CSF-1 responsive subclones produced less protein than the mass transfected population.
Enforced expression of cdc25A accelerates S phase entry
Cdc25A is a target of c-myc, and enforced expression of c-myc can accelerate G1 phase progression in rodent ®broblasts (Karn et al., 1989; Eilers et al., 1991) . Therefore, we evaluated whether ectopically expressed cdc25A might also aect the duration of G1 phase as quiescent cells are brought into the division cycle. Cells overexpressing cdc25A displayed a consistent shortening of their G1 phase by 2 ± 3 h. As shown in Figure  2a , control cells began to replicate their DNA approximately 12 h after serum addition, as marked by the appearance of cells with DNA content greater than 2N. In contrast, cells overexpressing human cdc25A entered S phase 10 h after serum stimulation, and at later times, a signi®cantly higher percentage of S phase cells was detected in cells overexpressing cdc25A compared to control cells. Since serum starvation resulted in cell death and therefore in a loss of a signi®cant number of cells that overexpressed cdc25A, cells were subsequently synchronized by contact inhibition and replated at lower density in serumcontaining medium. This method of synchronization and a clone of transfected cells engineered to express cdc25A (right column) were made quiescent by serum withdrawal for 48 h and were subsequently stimulated with 10% fetal calf serum to enter the cell cycle. Cells were analysed for DNA content by¯ow cytometry at the indicated times after serum restimulation. (b) Cells arrested by contact inhibition were restimulated to enter the cycle by replating at a lower density, and the cultures were analysed using a BrdU/PI double-staining protocol Cdc25 tyrosine phosphatase V Sexl et al resulted in a comparable contraction of the G1 phase in cells overexpressing cdc25A (data not shown), and was used in subsequent experiments. We detected a G1 shortening of about 2 ± 3 h in cells overexpressing cdc25A in six out of six independent experiments using dierent CSF-1 derived subclones. To con®rm that their G1 interval was contracted, the mass population of cells expressing cdc25A was studied using a more sensitive BrdU/PI double-staining method. Cells were arrested by contact inhibition, and quiescent cells were then stimulated to re-enter the cell cycle by replating at low density in serum-containing medium. Replicate cultures were labeled with BrdU for 30 min prior to harvesting at dierent times after serum stimulation, and the onset of DNA replication was monitored by staining with antibody directed against BrdU combined with¯ow cytometric analysis of their DNA content by propidium iodide staining ( Figure 2b ). BrdU/PI double staining revealed that the mass population of cells overexpressing cdc25A entered S phase earlier, 8 h after replating, as compared to the parental cells that initiated DNA synthesis 13 ± 14 h after serum stimulation. The less dramatic shortening of G1 phase observed in single cell-derived subclones overexpressing cdc25A is most likely due to the reduced expression of cdc25A in these cells compared to that in the mass population, as well as to the higher sensitivity of the BrdU/PI staining method.
Molecular markers of passage through the late G1 phase restriction point and subsequent entry into S phase include: (i) degradation of the cdk inhibitor p27
Kip1 in late G1; (ii) activation of cyclin E-dependent kinase; and (iii) induction and activation of cyclin Adependent kinase just before cells enter S phase. Each of these parameters was measured in parental, untransfected cells and in those engineered to overexpress cdc25A (Figure 3) . When contact-inhibited cells were stimulated to re-enter the cell cycle, p27
Kip1 was degraded signi®cantly earlier in cells enforced to express cdc25A (Figure 3a) , whereas no dierence was observed in the steady-state levels of the cdk inhibitor, p21
Cip1 (Figure 3b ). The levels of cyclin Edependent kinase activity were generally low in these cells, but were upregulated as cells entered the cycle after release from contact inhibition (Figure 3c ). Under these conditions, we were unable to document any Figure 3 Analysis of cdk inhibitors and cdk activity in cells entering S phase. Parental cells and derivatives overexpressing cdc25A were arrested by contact-inhibition and then trypsinized and stimulated with serum to synchronously enter the cell cycle. Cells, harvested at indicated times (h) after serum stimulation, were analysed by FACS for DNA content. The vertical arrows at the bottom of the panel indicate the onset of DNA synthesis. Aliquots of cell lysates were analysed by immunoblotting for p27 Kip1 (a) and p21
Cip1 (b) expression, and for cyclin E-dependent (c), cyclin A-dependent (d), and total cdk2 kinase (e) activities using histone H1 as substrate. For cyclin E-dependent kinase, 300 mg of protein were immunoprecipitated, and histone H1 phosphorylation was detected after 12 h exposure on a PhosphorImager screen. For cyclin A-dependent (300 mg protein) and total cdk2 (200 mg protein) activity, H1 phosphorylation was detected after a 20 min autoradiographic exposure. Cyclin D1-dependent kinase activity (f) was assayed using a GST-Rb fusion protein as substrate, exactly as described (Matsushime et al., 1994) Cdc25 tyrosine phosphatase V Sexl et al signi®cant dierences in the onset of cyclin Edependent cdk2 activity between parental cells and those overexpressing cdc25A as they approached the G1/S transition. Similarly we were unable to detect any signi®cant dierences in cyclin D-dependent kinase activity ( Figure 3f ). However, consistent with the more rapid loss of the p27 Kip1 inhibitor in cells overexpressing cdc25A (Figure 3a) , the temporal appearance of cyclin A-dependent kinase activity (Figure 3d ) and total cdk2 activity ( Figure 3e ) were accelerated by several hours, again correlating with the premature entry of these cells into S phase (Figure 2) . Together, these data suggest that cdc25A activity may be rate limiting for G1 progression.
Conceivably, the ability of cdc25A to accelerate G1 progression might not depend upon its phosphatase activity. To address this point, we established cell lines ectopically overexpressing a catalytically inactive cdc25A mutant (C430S), which can bind to, but not dephosphorylate, tyrosine phosphorylated in vitro substrates (Gautier et al., 1991; Xu and Burke, 1996) . Although the cells displayed comparable levels of ectopic overexpression of the mutant versus wild-type enzyme, cells infected with mutant cdc25A neither demonstrated any shortening of G1 nor premature activation of the cdk2 kinase (negative data not shown). At face value, then, these data argue for a role of cdc25A's phosphatase activity and suggest that dephosphorylation of tyrosine phosphorylated substrates is the mechanism that underlies the observed G1 phase contraction.
Paradoxical increase in cdk2 tyrosine phosphorylation in cells overexpressing cdc25A
In vitro, cdc25A is able to remove inhibitory phosphate groups from threonine-14 and tyrosine-15 of cdk2, and so, it has been generally assumed that cdk2 is a physiologic substrate of cdc25A in vivo (Homann et al., 1994; Xu and Burke, 1996; Tiefenbrun et al., 1996; Saha et al., 1997) . We therefore attempted to establish a temporal link between enforced expression of cdc25A and premature dephosphorylation of cdk2 as cells entered S phase, by analysing the relative content of phosphotyrosine in cdk2. Parental cells and the mass population of cells engineered to overexpress cdc25A were synchronized by growth-inhibition at con¯uence and allowed to re-enter the cell cycle at low density in serum-containing medium. Cdk2 was immunoprecipitated from cell lysates harvested at dierent times following serum stimulation and immunoblotted sequentially with antibodies to both phosphotyrosine (anti-P-Tyr) and to cdk2 itself. Although the overall levels of cdk2 remained constant (Figure 4a ), cdk2 surprisingly acquired more tyrosine phosphate as cells entered S phase (Figure 4b ). Indeed, we saw rapid phosphorylation of cdk2 on tyrosine and we recovered somewhat more cdk2 phosphorylated on tyrosine from cells overexpressing cdc25A than from control cells. Virtually identical results were obtained using antibodies to P-Tyr from several sources (data not shown).
The majority of serum-stimulated cdk2 activity is associated with cyclin A (Figure 3c ± e) . As expected, cdk2 was found to be mainly bound to cyclin A and only a small proportion of cdk2 molecules was bound to cyclin E, regardless of whether the cells overexpressed cdc25A or not (data not shown). To rule out the possibility that cdc25A exclusively targets the small fraction of cdk2 molecules bound to cyclin E, we immunoprecipitated cyclin E-dependent complexes and analysed them separately. The levels of cdk2 associated with cyclin E remained constant during cell cycle progression (Figure 4c) . In a comparable manner, parental cells and cells overexpressing cdc25A acquired tyrosine phosphate on cyclin E-associated cdk2 as cells approached S phase (Figure 4d ). Hence, these data are incompatible with the concept that cdc25A speci®cally targets cyclin E/cdk2 complexes.
To verify increased tyrosine phosphorylation of cdk2 in cells overexpressing cdc25A by an independent method, parental cells and cells overexpressing cdc25A were metabolically labeled with 32 P-orthophosphate. Radiolabeled cdk2 was recovered by immunoprecipitation ( Figure 5a, left panel) , and the gel-puri®ed protein was subjected to phosphoamino acid analysis (Figure 5a, right panel) . The ratio of phosphotyrosine to phosphoserine in recovered cdk2 was higher in cells overexpressing cdc25A as measured by PhosphorImager analysis (0.5 versus 0.2, respectively, average of two experiments). To demonstrate that all phosphotyrosines detected on cdk2 were restricted to tyrosine-15, we used a mutant hemagglutinin-tagged version of cdk2 in which the inhibitory phosphorylation sites, Thr-14 and Tyr-15 were replaced by alanine and phenylalanine, respectively (the`AF' mutant) (Gu et al., 1992) . Cdk2-AF or wild-type cdk2 were transiently transfected into parental ®broblasts, and cdk2-AF was recovered by immunoprecipitation with the anti-HA antibody from cells harvested 36 h after transfection, when the cells were still proliferating. The cdk2-AF mutant lacked phosphotyrosine as Figure 4 Cdk2 phosphorylation on tyrosine as cells enter S phase. Fibroblasts arrested by contact-inhibition were stimulated to synchronously re-enter the cycle. Cells harvested at various times thereafter were lysed and precipitated with anity-puri®ed antibodies directed to the cdk2 C-terminus (a,b) or to cyclin E (c,d). Proteins separated on gels and transferred to nitrocellulose were probed with a monoclonal antibody directed against phosphotyrosine (b,d) and then stripped and reprobed with antiserum to cdk2 (a,c) Cdc25 tyrosine phosphatase V Sexl et al expected, whereas transiently expressed wild-type cdk2 contained readily detectable tyrosine phosphate ( Figure  5b ). These results indicate that phosphotyrosine on cdk2 is restricted to Tyr-15 and that the increased tyrosine phosphorylation of cdk2 that is observed as cells enter S phase occurs only on this residue.
Discussion
The cdc25A gene is expressed during the G1 phase of the cell cycle following serum stimulation of quiescent ®broblasts, and its activity appears to be required for cells to enter S phase (Jinno et al., 1994) . This phosphatase is widely assumed to activate cdk2 in complexes with cyclins E and/or A as cycling cells enter S phase (Homann et al., 1994; Tiefenbrun et al., 1996; Xu and Burke, 1996; Saha et al., 1997) . In particular circumstances, it may also dephosphorylate cdk4 in certain cells, reversing checkpoint inhibition in response to UV irradiation (Terada et al., 1995), or TGF-b (Iavarone and MassagueÂ , 1997) .
Given that cdk2 participates in Rb phosphorylation and inactivation (Hinds et al., 1992; Hatakeyama et al., 1994; Connell-Crowley et al., 1997; Lundberg and Weinberg, 1998) , phosphorylates p27
Kip1 to trigger its degradation Shea et al., 1997) and, likely recognizes other key substrates whose activities are necessary to trigger DNA replication (Ohtsubo et al., 1995; Lukas et al., 1997; Krude et al., Figure 5 Phosphorylation of cdk2 on tyrosine. (a) Parental cells and derivatives overexpressing cdc25A (cdc25A+) were labeled with 32 P-orthophosphate, and cdk2 was immunoprecipitated and electrophoretically resolved on denaturing polyacrylamide gels. Lysates precipitated with nonimmune rabbit serum (NRS) lacked the immunoprecipitable band (left panel). The recovered cdk2 protein was hydrolyzed, and phosphoamino acids were resolved by two-dimensional electrophoresis. The positions of the origin (ORI), phosphoserine (S), phosphothreonine (THR), and phosphotyrosine (TYR) are noted. The ratio of P-Tyr to P-Ser in parental and cdc25A+ cells was 0.2 versus 0.5, respectively (average of two experiments). (b) Parental cells were transfected with vectors encoding cdk2 or the cdk2-AF mutant. Wild-type cdk2 was precipitated from cell lysates using cognate antiserum, whereas the cdk2-AF mutant was recovered using antibodies to the HA-tag. Proteins resolved on denaturing gels were transferred to membranes and blotted with antiserum to cdk2 (left panel), anti-P-Tyr (middle and right; 1 and 3 min chemiluminescent exposures, respectively). Note that endogenous, tyrosine phosphorylated cdk2 can be detected in the latter exposure, whereas no P-Tyr is detected on the overexpressed cdk2-AF mutant. The heavy signal toward the end of the gel represents immunoglobulin light chain (IgL noted at the left margin) Cdc25 tyrosine phosphatase V Sexl et al 1997), a growth promoting role for cdc25A might well be expected. In agreement, cdc25A and B (but not C) can cooperate with activated Ha-ras in oncogenic ®broblast transformation, yielding variants that are tumorigenic in nude mice; similarly, cdc25A can itself transform Rb-null mouse embryo ®broblasts (Galaktionov et al., 1995b) . Moreover, the c-myc protooncogene product, in association with its partner Max, can transcriptionally activate cdc25A (Galaktionov et al., 1996) . Like myc itself, overexpression of cdc25A was found to trigger apoptosis in mitogen-depleted cells, and conversely, myc-induced apoptosis was reduced in cells engineered to express antisense coding sequences of cdc25A.
The implication that cdc25A is a mediator of Myc function motivated us to test its activity in a complementation assay in which mitogen-dependent entry of quiescent NIH3T3 ®broblasts into S phase and colony formation in semi-solid medium both absolutely depend upon Myc function . NIH3T3 cells engineered to express a mutant form (Y809F) of CSF-1R are partially defective in signaling, undergoing CSF-1-dependent induction of some immediate early genes (e.g. fos, jun) but not others (e.g. myc). Ectopic expression of myc in these cells is sucient to completely restore their mitogenicity, enabling them to proliferate in chemically-de®ned medium containing CSF-1 as the only added growth factor and to form anchorage-independent colonies in agar in the presence of medium containing both CSF-1 and serum. When cdc25A was introduced into cells bearing CSF-1R (Y809F), clones ectopically overexpressing the human phosphatase were able to form colonies in semi-solid medium containing CSF-1. However, they remained unable to proliferate continuously in serum-free medium containing CSF-1 alone, and their eciency of colony formation in agar was signi®cantly reduced if they were co-transfected with a vector encoding a dominant-negative myc (In 373) gene or the myc antagonist mad. Therefore, cdc25A overexpression was able to replace some functions of Myc but not others, and Myc function was still required for these cells to enter S phase.
Although, as previously reported (Galaktionov et al., 1996) , ®broblasts overexpressing cdc25A undergo accelerated apoptosis when deprived of serum growth factors, such cells could be viably arrested at con¯uence in the presence of medium containing 10% serum. When cells were brought synchronously into cycle by trypsinization and replating in complete serum-containing medium, cdc25A expression was found to shorten their G1 interval by 2 ± 3 h. This was a reproducible and signi®cant ®nding that was obtained with the uncloned transfected (mass) population of cells overexpressing cdc25A as well as with several independently derived agar subclones. Consistent with their premature entry into S phase, cells overexpressing cdc25A manifested an earlier degradation of p27
Kip1 in late G1 phase and a more rapid induction of cyclin A-associated cdk2 kinase activity.
Although the simplest interpretation is that cdc25A acts directly on cdk2 to prematurely activate the cyclin E-and A-dependent holoenzymes, our data do not support this interpretation. First, cdk2 was not detectably phosphorylated on tyrosine in contactinhibited quiescent cells or throughout most of the subsequent G1 phase of the cell cycle. Second, although the total level of cdk2 was unchanged as con¯uent cells re-entered the division cycle and progressed into S phase, total phosphotyrosine levels in cdk2 paradoxically increased, rather than decreased, as DNA replication began. The increase in cdk2 phosphotyrosine content was accelerated in cells overexpressing cdc25A, consistent with their contracted G1 phase interval. We also excluded the possibility that cdc25A could speci®cally target cyclin E-cdk2 complexes, which represented a minority population compared to cyclin A-cdk2 as cells entered S phase. The results of P-Tyr immunoblotting were con®rmed by metabolic labeling and phosphoamino acid analysis of 32 P-labeled cdk2, which indicated that cdk2 recovered from cells overexpressing cdc25A contained more P-Tyr relative to P-Ser than control, parental cells. Finally, when cdk2 was itself ectopically expressed, all P-Tyr in the molecule was found to reside at Tyr-15, since a cdk2 mutant containing a phenylalanine for tyrosine substitution at this position could not be radiolabeled with 32 P-orthophosphate. The latter data con®rm those of a previous report that indicated that cdk2 underwent increased phosphorylation on tyrosine as cells synchronously entered S phase (Gu et al., 1992) . These results are therefore more consistent with an underlying feedback control mechanism, in which the enzymatic activity of some cdk2 molecules might be limited by inhibitory tyrosine phosphorylation once cells enter S phase. Consistent with this idea, cells do not tolerate the stable expression of cdk2 mutants, which lack Tyr-15 (Gu et al., 1992) . Our eorts to establish stable cell lines that express the K2AF-mutant of cdk2 also failed.
Although we cannot exclude the possibility that a privileged population of cdk2 molecules is necessary for S phase entry and that these might be dephosphorylated by cdc25A, an obvious alternative hypothesis is that cdk2 is not the physiologic target of the enzyme. A role for cdk4 as a target for cdc25A during the unchecked proliferative cycle is unlikely for two reasons. First, we failed to detect any acceleration of cdk4-associated kinase activity in cells overexpressing cdc25A. Second, although others successfully detected tyrosine-phosphorylated cdk4 in some cell types (Terada et al., 1995; Iavarone and MassagueÂ , 1997) , we were unable to detect phosphotyrosine on cdk4 under various conditions in NIH3T3 ®broblasts (cycling cells, serum starvation, UV irradiation) using dierent anti-phosphotyrosine antibodies. Further work attempting to identify physiologic in vivo substrates of cdc25A is therefore clearly warranted.
Materials and methods
Cells and culture conditions
NIH3T3 cells were cultured in 8% CO 2 at 378C in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, and 100 U ml 71 penicillin and streptomycin (Gibco/BRL, Gaithersburg, MD). NIH3T3 cells expressing a mutant CSF-1 receptor (Y809F) that is partially defective in signal transduction (Roussel et al., 1990 , were transfected with 15 mg expression plasmid encoding cdc25A together with 5 mg of pJ6O-puro (Morgenstern and Land, 1990), Cdc25 tyrosine phosphatase V Sexl et al which confers resistance to the protein synthesis inhibitor, puromycin. Cells were selected and maintained in complete medium containing 7.5 mg/ml puromycin. Single cellderived colonies were obtained in soft agar by plating the cells in complete medium containing 0.1 mg/ml of puri®ed human recombinant CSF-1 per ml (kindly provided by Steve Clark, Genetics Institute, Cambridge, MA). Although NIH3T3 cells bearing a wild-type human CSF-1 receptor can form colonies in agar in response to ligand, those bearing the mutant CSF-1R (Y809F) receptor cannot. However, their ability to proliferate in response to CSF-1 can be rescued by c-myc , Dtype cyclins (Roussel et al., 1995) or by cdc25A. Colonies derived from single cells were expanded and tested for cdc25A expression, as well as for their ability to proliferate in chemically de®ned liquid medium containing CSF-1 as the only growth factor.
For studies involving S phase entry, two approaches were used to synchronize the cells: in experiments shown in Figure  2a , the cells were plated at low density in serum-containing medium, and cells were made quiescent by switching them into serum-free medium for 36 h. The cultures were then refed with serum-containing medium. However, serum starvation resulted in the death of a signi®cant portion of cells that overexpressed cdc25A, resulting in selection for survivors ectopically expressing only low levels of the enzyme. Therefore, for all subsequent experiments shown in Figures  2b, 3 and 4, synchronization of cells was performed by bringing cells to con¯uence in serum-containing medium for 2 days. Cells were then trypsinized, replated at 60% density to allow cell cycle progression, and DNA synthesis was monitored by¯ow cytometric analysis of DNA content (Matsushime et al., 1991) .
BrdU/PI double staining
Parental as well as cdc25A-overexpressing cells (masspopulation) were synchronized by contact inhibition for 36 h and subsequently replated at 60% density. The cells were incubated with 65 mM BrdU for 30 min prior to harvesting at the indicating time points. Brie¯y, cells were ®xed in 70% ethanol. Fixed cells were incubated in 4N HCl for 30 min at room temperature, washed with phosphatebuered saline (PBS), and resuspended in 0.1 M Borax containing 0.1% Tween-20 and 0.1% BSA. Cells were exposed for 30 min at room temperature to monoclonal anti-BrdU (Beckton-Dickinson, San Jose, CA) or to isotype-matched control mouse immunoglobulin G (IgG), washed with PBS and counterstained for 30 min with uorescein-conjugated goat antibodies to mouse IgG (Coulter, Hialeah, FL). Washed cells were resuspended in PBS containing 0.5% BSA, 20 mg/ml propidium iodide, and 50 mg/ml DNAse-free RNAse (Calbiochem). Fluorescence from FITC-labeled incorporated BrdU and propidium iodide-DNA complexes was measured on a FACSCalibur¯ow cytometer (Beckton Dickinson) using 488 nm laser excitation. Cell debris and background artifacts were electronically gated out, and the percentages of cells in dierent cell cycle phases were computed using CellQuest software (Beckton Dickinson).
Vector virus production and infection
Human kidney 293T cells (provided by David Baltimore, Institute of Technology, CA) were co-transfected with 15 mg of ecotropic helper virus DNA plasmid and 15 mg of pBabepuro vector DNA encoding wild-type cdc25A, or a catalytically inactive mutant of cdc25A (C430S) (Gautier et al., 1991; Galaktionov et al., 1996; Xu and Burke, 1996) . Cell supernatants containing infectious retroviral pseudotypes were harvested 24 to 60 h post-transfection, pooled on ice and ®ltered (0.45 mm membrane). Infections of exponentially growing ®broblasts were performed in an 8% CO 2 atmosphere with 3 ml of virus-containing culturesupernatant containing 10 mg/ml polybrene (Sigma, St. Louis, MO) per 100 mm dish. After 6 h, 10 ml of fresh medium was added, and cells reached con¯uence 30 h after infection. Cells infected with pBabepuro vector alone were used as control.
Cdc25A protein analysis
Cells harvested by trypsinization were centrifuged and lysed in immunoprecipitation buer (IP-buer) containing: 50 mM HEPES, pH 7.5, 0.1% Tween-20, 150 mM NaCl, 1 mM EDTA, 20 mM b-glycerophosphate, 0.1 mM sodium vanadate, 1 mM sodium¯uoride, 10 mg/ml each aprotinin and leupeptin (both from Sigma Chemicals, St. Louis, MO), and 1 mM phenylmethylsulfonyl¯uoride (PMSF). After brief sonication, lysates were cleared of nuclear debris by centrifugation. Protein concentrations were determined using a BCA protein assay kit as recommended by the manufacturer (Pierce, Rockford, IL). For immunoprecipitation of cdc25A, 1.5 mg protein from cell lysates was incubated for 6 ± 8 h at 48C with 1 mg of anity-puri®ed antibody directed against the C-terminus of cdc25A (Galaktionov et al., 1995a) followed by 1 hr at 48C with 40 ml of protein A-Sepharose. Immunoprecipitates were re-suspended in 40 ml sample buer and electrophoretically resolved on denaturing 7% polyacrylamide gels containing sodium dodecyl sulfate (SDS) before transfer onto Immobilon membranes (Millipore, Bedford, MA). Membranes were probed with an antiserum directed to the full length cdc25A protein (Galaktionov et al., 1995a) , and sites of antibody binding were visualized using protein A-conjugated horse-radish peroxidase (EY Laboratories, San Mateo, CA) with chemiluminescent detection (ECL detection kit, Amersham, Arlington Heights, IL).
Western blot analysis of p27
Kip1 and p21
Cip1
To assess expression levels of the cdk inhibitor proteins p27 Kip1 and p21 Cip1 , cells were lysed in IP buer, and 100 mg of total protein per lane were electrophoretically resolved on a 12% polyacrylamide gel containing SDS and transferred onto Immobilon membrane. Membranes were either probed with an anity-puri®ed antiserum directed against p21
Cip-1 (sc-397, Santa Cruz, CA) or to the full length mouse p27
Kip1 . Sites of antibody binding were visualized as described above.
Protein kinase assays
Cells were synchronized by contact inhibition, and entry into the cell cycle was reinitiated by trypsinizing and diluting the cells four-fold before replating them in complete serum-containing medium. At dierent times thereafter, replicate cultures were harvested by trypsinization and divided in two. One aliquot was stained with propidium iodide for analysis of their DNA content by FACS, and the other was pelleted and stored at 7808C. Cell pellets were lysed and sonicated in IP buer. Lysate (300 mg protein per sample) was incubated with 1 mg antibody directed against cyclin E or cyclin A (sc-481 and sc-596, respectively, Santa Cruz, CA), or total lysate (200 mg per sample) was directly exposed to anitypuri®ed antiserum directed against the 10 C-terminal amino acids of cdk2 . Immunoprecipitates were suspended in 30 ml kinase buer (50 mM HEPES, pH 8.0, containing 10 mM MgCl 2 , 1 mM DTT, 10 mM unlabeled ATP, 1 mM sodium vanadate, 1 mM sodium¯uoride, 1 mM PMSF and 10 mg/ml aprotinin). Kinase reactions were then initiated by adding 10 mCi of [g-32 ATP] (6000 Ci/mmol, New England Nuclear, Boston, Cdc25 tyrosine phosphatase V Sexl et al MA) and 1 mg histone H1 per sample (BoehringerMannheim, Germany) and incubating at 378C for 15 min (with linear incorporation kinetics). Labeled products were denatured in SDS sample buer and separated on denaturing polyacrylamide gels prior to autoradiography. For the analysis of cyclin D-dependent kinase activity, 1 mg of cell lysate was incubated for 2 h with protein A Sepharose beads pre-coated with saturating amounts of mouse monoclonal cyclin D1 antibody, D1-72-13G (Matsushime et al., 1994) . Immunoprecipitated proteins on the beads were washed and resuspended in 30 ml of kinase buer and 0.4 mg of soluble glutathione-S-transferase-Rb fusion protein. After incubation for 30 min at 308C with occasional mixing, the samples were boiled in SDS sample buer and separated by electrophoresis.
Tyrosine phosphorylation of cdk2
Cells were synchronized by contact inhibition and then stimulated to re-enter the cell cycle by trypsinization and replating in complete serum-containing medium. Cells were harvested at various times thereafter, and cell pellets were stored at 7808C until analysed. Cell pellets were lysed in IP buer, and each cell lysate (2 mg protein) was incubated with an anity-puri®ed rabbit polyclonal antiserum directed against the C-terminus of cdk2 . For detection of cyclin E-associated tyrosine phosphorylation on cdk2, 6 mg of cell lysate protein were precipitated with rabbit antiserum directed to the Cterminus of cyclin E (sc-481, Santa Cruz, CA). Washed immunoprecipitates were resuspended in 40 ml SDS sample buer, resolved electrophoretically on a 12% polyacrylamide gel containing SDS, and transferred onto Immobilon membranes. Membranes were probed with an antibody against phosphotyrosine (4G10, UBI, Lake Placid, NY), and sites of antibody binding were visualized with a horseradish peroxidase-conjugated rabbit antiserum to mouse immunoglobulin G (Amersham, Arlington Heights, IL) followed by chemiluminescent detection (ECL detection kit, Amersham, Arlington Heights, IL). Membranes were then reprobed with the antiserum directed against cdk2.
Phosphoamino acid analysis
Proliferating cells at 60% con¯uence were washed twice with phosphate-free medium followed by a 1 h preincubation with phosphate-free medium containing 10% dialyzed FBS. Cells were metabolically labeled for 2 h in the same medium with 1 mCi/ml of carrier-free [ 32 P]-orthophosphate (ICN, Costa Mesa, CA) and lysed in 50 mM Tris-HCl, pH 7.5, containing 150 mM NaCl, 1% Nonidet P-40, 1% deoxycholate, 0.1% SDS, 20 mM b-glycerophosphate, 0.1 mM sodium vanadate, 1 mM sodium¯uoride, 10 mg/ml each aprotinin and leupeptin, and 1 mM PMSF. Radiolabeled cdk2 was isolated by immunoprecipitation, resolved electrophoretically on denaturing gels, and transferred to Immobilon-P membranes (Millipore). After visualization of cdk2 by autoradiography, the ®lter-bound protein was excised and hydrolyzed in 6 M HCl at 1008C for 60 min. Phosphoamino acids were then separated by two-dimensional electrophoresis using an HTLE-7000 apparatus (CBS Scienti®c, Del Mar, CA) as described (Boyle et al., 1991; Diehl et al., 1997) . Mixed internal phosphoamino acid standards were visualized with Ninhydrin spray, and 32 P-labeled amino acids were quantitated by PhosphorImaging.
